What are the benefits for international clients conducting clinical trials in Australia?
We have an extremely favourable regulatory system for clinical trials here in Australia. With no IND required and fast-track approvals, Australian (TGA) clinical trial start-up times are typically 4-6 months faster than US (FDA) trials, so you can fast-track your FDA and EMA submissions. Moreover, Australian trials are much cheaper – often a third of the cost – thanks in no small part to a generous R&D cash incentive from the Australian Government.
Read more about the advantages of choosing Linear and Australia, and find out how our concept-to-commercialisation capabilities will add value at every stage of your therapy’s journey to market, including taking advantage of Australia’s cash back for R&D expenses. Talk to our team.